Flunixin meglumine 5 % w/v = 50 mg/ - search results

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

emdofluxin 50 mg/ml inj. sol. i.v./i.m. vial

emdoka s.p.r.l.-b.v.b.a. - flunixin meglumine 82,94 mg/ml - eq. flunixin 50 mg/ml - solution for injection - 50 mg/ml - flunixin meglumine 82.94 mg/ml - flunixin - cattle; pig; horse

United States - English - NLM (National Library of Medicine)

banamine- flunixin meglumine solution

merck sharp & dohme corp. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin 50 mg in 1 ml - indications: banamine transdermal pour-on is indicated for the control of pyrexia associated with bovine respiratory disease and acute bovine mastitis, and the control of pain associated with foot rot in beef cattle 2 months of age and older and dairy cattle. not for use in beef and dairy bulls intended for breeding over 1 year of age, replacement dairy heifers over 20 months of age, dry dairy cows, dairy calves, or veal calves. contraindications: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use banamine transdermal pour-on within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine.

Ireland - English - HPRA (Health Products Regulatory Authority)

finadyne transdermal 50 mg/ml pour-on solution for cattle

intervet ireland limited - flunixin meglumine - pour-on solution - 50 milligram(s)/millilitre - flunixin - cattle - n.s.a.i.d.

Ireland - English - HPRA (Health Products Regulatory Authority)

dugnixon 50 mg/ml solution for injection for cattle, pigs and horses

global vet health sl - flunixin meglumine - solution for injection - 50 milligram(s)/millilitre - flunixin - cattle, horses, pigs - n.s.a.i.d.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neove flunixin meglumine injection

Ireland - English - HPRA (Health Products Regulatory Authority)

flunazine 50 mg/ml solution for injection for cattle, horses and pigs

bimeda animal health limited - flunixin meglumine - solution for injection - 50 milligram(s)/millilitre - flunixin

United States - English - NLM (National Library of Medicine)

vetameg- flunixin meglumine injection

aspen veterinary resources - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - indications horse: vetameg (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: vetameg (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. vetameg is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of still birth. do not use vetameg (flunixin meglumine injection)within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected. safety horse: a 3-fold intramuscular dose of 1.5 mg/lb of body weight daily for 10 consecutive days was safe. no changes were observed in hematology, serum chemistry, or urinalysis values. intravenous dosages of 0.5 mg/lb daily for 15 days; 1.5 mg/lb daily for 10 days; and 2.5 mg/lb daily for 5 days produced no changes in blood or urine parameters. no injection site irritation was observed following intramuscular injection of the 0.5 mg/lb recommended dose. some irritation was observed following a 3-fold dose administered intramuscularly. cattle: no flunixin-related changes (adverse reactions) were noted in cattle administered a 1x (2.2 mg/kg; 1.0 mg/lb) dose for 9 days three times the maximum clinical duration. minimal toxicity manifested itself at moderately elevated doses (3x and 5x) when flunixin was administered daily for 9 days, with occasional findings of blood in the feces and/or urine. discontinue use if hematuria or fecal blood are observed.

Ireland - English - HPRA (Health Products Regulatory Authority)

flunixin injection

norbrook laboratories (ireland) limited - flunixin meglumine - solution for injection - 50 milligram(s)/millilitre - flunixin

Canada - English - Health Canada

influx-50 (flunixin meglumine injection) sterile injectable solution

vetoquinol n a inc - flunixin (flunixin meglumine) - solution - 50mg - flunixin (flunixin meglumine) 50mg - horses

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

flumav flunixin injection